These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35089807)
1. FoxO4 controls sGCβ transcription in vascular smooth muscle. Galley JC; Miller MP; Sanker S; Liu M; Sharina I; Martin E; Gomez D; Straub AC Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H417-H426. PubMed ID: 35089807 [TBL] [Abstract][Full Text] [Related]
2. Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression. Galley JC; Durgin BG; Miller MP; Hahn SA; Yuan S; Wood KC; Straub AC Mol Pharmacol; 2019 Jun; 95(6):629-637. PubMed ID: 30988014 [TBL] [Abstract][Full Text] [Related]
3. Functional Characterization of the Kessler T; Wobst J; Wolf B; Eckhold J; Vilne B; Hollstein R; von Ameln S; Dang TA; Sager HB; Moritz Rumpf P; Aherrahrou R; Kastrati A; Björkegren JLM; Erdmann J; Lusis AJ; Civelek M; Kaiser FJ; Schunkert H Circulation; 2017 Aug; 136(5):476-489. PubMed ID: 28487391 [TBL] [Abstract][Full Text] [Related]
4. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex. Dai Y; Stuehr DJ Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of soluble guanylyl cyclase in living cells proceeds without loss of haem and involves heterodimer dissociation as a common step. Dai Y; Stuehr DJ Br J Pharmacol; 2022 Jun; 179(11):2505-2518. PubMed ID: 33975383 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. Browner NC; Dey NB; Bloch KD; Lincoln TM J Biol Chem; 2004 Nov; 279(45):46631-6. PubMed ID: 15337747 [TBL] [Abstract][Full Text] [Related]
9. Proatherosclerotic Effect of the α1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic Switching. Segura-Puimedon M; Mergia E; Al-Hasani J; Aherrahrou R; Stoelting S; Kremer F; Freyer J; Koesling D; Erdmann J; Schunkert H; de Wit C; Aherrahrou Z Am J Pathol; 2016 Aug; 186(8):2220-2231. PubMed ID: 27315776 [TBL] [Abstract][Full Text] [Related]
10. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808 [TBL] [Abstract][Full Text] [Related]
11. The β subunit of soluble guanylyl cyclase GUCY1B3 exerts cardioprotective effects against ischemic injury via the PKCε/Akt pathway. Wang X; Du W; Li M; Zhang Y; Li H; Sun K; Liu J; Dong P; Meng X; Yi W; Yang L; Zhao R; Hu J J Cell Biochem; 2019 Mar; 120(3):3071-3081. PubMed ID: 30485489 [TBL] [Abstract][Full Text] [Related]
12. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells. El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655 [TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 regulates soluble guanylyl cyclase maturation by a dual mechanism. Dai Y; Schlanger S; Haque MM; Misra S; Stuehr DJ J Biol Chem; 2019 Aug; 294(35):12880-12891. PubMed ID: 31311859 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells. Bachiller PR; Nakanishi H; Roberts JD Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II augments renal vascular smooth muscle soluble GC expression via an AT Galley JC; Hahn SA; Miller MP; Durgin BG; Jackson EK; Stocker SD; Straub AC Br J Pharmacol; 2022 Jun; 179(11):2490-2504. PubMed ID: 33963547 [TBL] [Abstract][Full Text] [Related]
16. Co-expression of soluble guanylyl cyclase subunits and PDE5A shRNA to elevate cellular cGMP level: A potential gene therapy for myocardial cell death. Jing G; Xia Z; Lei Q Technol Health Care; 2023; 31(3):901-910. PubMed ID: 36442224 [TBL] [Abstract][Full Text] [Related]
17. Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress. Durgin BG; Wood KC; Hahn SA; McMahon B; Baust JJ; Straub AC J Mol Cell Cardiol; 2022 Jan; 162():72-80. PubMed ID: 34536439 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling. Du L; Roberts JD Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L20-L34. PubMed ID: 30260287 [TBL] [Abstract][Full Text] [Related]
20. NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase. Park M; Choi S; Kim S; Kim J; Lee DK; Park W; Kim T; Jung J; Hwang JY; Won MH; Ryoo S; Kang SG; Ha KS; Kwon YG; Kim YM Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30765689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]